BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center

SAN DIEGO, April 30 /PRNewswire-FirstCall/ — BioMed Realty Trust, Inc.
(NYSE: BMR) today announced the signing of a new ten-year lease for more
than 140,000 square feet at the Pacific Research Center, BioMed’s Newark,
California multi-tenant research campus. DayStar Technologies, Inc.
(Nasdaq: DSTI) will join BioMed’s rapidly expanding roster of tenants at
the Pacific Research Center in the East Bay of San Francisco’s thriving
technology corridor.

DayStar is engaged in the development, manufacturing and marketing of
solar photovoltaic products utilizing its proprietary thin film deposition
technology. DayStar’s Chief Executive Officer, Dr. Stephan DeLuca, said,
“The Pacific Research Center is an ideal location with excellent facilities
that meet our needs as we build our manufacturing capacity.”

Alan Gold, BioMed’s President and Chief Executive Officer, commented,
“It is with great excitement that we welcome Dr. DeLuca and his world-class
team to our Newark campus. This lease further demonstrates our ability to
deliver on our business model of making Pacific Research Center a thriving
multi-tenant research and production campus. DayStar’s long-term addition
to the campus translates into a significant win for both DayStar and
BioMed, and I congratulate our respective teams for bringing this deal to
fruition.”

About DayStar Technologies

DayStar Technologies, Inc. is engaged in the development, manufacturing
and marketing of photovoltaic products based upon CIGS thin film
semiconductor technology. For more information, visit the DayStar website
at http://www.daystartech.com.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT)
focused on Providing Real Estate to the Life Science Industry(R). The
company’s tenants primarily include biotechnology and pharmaceutical
companies, scientific research institutions, government agencies and other
entities involved in the life science industry. BioMed Realty Trust owns or
has interests in 69 properties, representing 112 buildings with
approximately 10.4 million rentable square feet, including approximately
1.9 million square feet of development in progress. The company also owns
undeveloped land parcels adjacent to existing properties that it estimates
can support up to 1.4 million rentable square feet. The company’s
properties are located predominantly in the major U.S. life science markets
of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and
New York/New Jersey, which have well-established reputations as centers for
scientific research. Additional information is available at
http://www.biomedrealty.com.

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 based on
current expectations, forecasts and assumptions that involve risks and
uncertainties that could cause actual outcomes and results to differ
materially. These risks and uncertainties include, without limitation:
general risks affecting the real estate industry (including, without
limitation, the inability to enter into or renew leases, dependence on
tenants’ financial condition, and competition from other developers, owners
and operators of real estate); adverse economic or real estate developments
in the life science industry or the company’s target markets; risks
associated with the availability and terms of financing and the use of debt
to fund acquisitions and developments; failure to manage effectively the
company’s growth and expansion into new markets, or to complete or
integrate acquisitions and developments successfully; risks and
uncertainties affecting property development and construction; risks
associated with downturns in the national and local economies, increases in
interest rates, and volatility in the securities markets; potential
liability for uninsured losses and environmental contamination; risks
associated with the company’s potential failure to qualify as a REIT under
the Internal Revenue Code of 1986, as amended, and possible adverse changes
in tax and environmental laws; and risks associated with the company’s
dependence on key personnel whose continued service is not guaranteed. For
a further list and description of such risks and uncertainties, see the
reports filed by the company with the Securities and Exchange Commission,
including the company’s most recent annual report on Form 10-K and
quarterly reports on Form 10-Q. The company disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.



See Also

Source: Real Estate Newswire

Leave a Reply